Terms: = Pancreatic cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Diagnosis
85 results:
1. Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib.
Ge W; Wang Y; Quan M; Mao T; Bischof EY; Xu H; Zhang X; Li S; Yue M; Ma J; Yang H; Wang L; Yu Z; Wang L; Cui J
Mol Cancer; 2024 Mar; 23(1):48. PubMed ID: 38459558
[TBL] [Abstract] [Full Text] [Related]
2. Twelve-month progression-free survival with sotorasib and panitumumab in KRAS G12C mutant metastatic colorectal cancer.
Kavgaci G; Dizdar O; Yalcin S
Anticancer Drugs; 2024 Jun; 35(5):459-461. PubMed ID: 38451823
[TBL] [Abstract] [Full Text] [Related]
3. Transcriptomic Signature of 3D Hierarchical Porous Chip Enriched Exosomes for Early Detection and Progression Monitoring of Hepatocellular Carcinoma.
Yi K; Wang Y; Rong Y; Bao Y; Liang Y; Chen Y; Liu F; Zhang S; He Y; Liu W; Zhu C; Wu L; Peng J; Chen H; Huang W; Yuan Y; Xie M; Wang F
Adv Sci (Weinh); 2024 Apr; 11(14):e2305204. PubMed ID: 38327127
[TBL] [Abstract] [Full Text] [Related]
4. Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv).
González-Moreno J; Gragera-Martínez Á; Rodríguez A; Borrachero-Garro C; García-Garrido S; Barceló C; Manovel-Sánchez A; Ribot-Sansó MA; Ibargüen-González L; Gomila R; Muñoz-Beamud F; Losada-López I; Cisneros-Barroso E
Sci Rep; 2024 Jan; 14(1):581. PubMed ID: 38182630
[TBL] [Abstract] [Full Text] [Related]
5. Exosome and lipid metabolism-related genes in pancreatic adenocarcinoma: a prognosis analysis.
Wu J; Li Y; Nabi G; Huang X; Zhang X; Wang Y; Huang L
Aging (Albany NY); 2023 Oct; 15(20):11331-11368. PubMed ID: 37857015
[TBL] [Abstract] [Full Text] [Related]
6. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
7. The prognostic role of epidermal growth factor receptor mutation in completely resected ampullary adenocarcinoma.
Varol U; Cakır E; Aktas S; Altun ZS; Dilek FH; Butun O; Salman T; Unlu AGD; Alacacioglu A; Somali I
Pol J Pathol; 2023; 74(1):18-28. PubMed ID: 37306349
[TBL] [Abstract] [Full Text] [Related]
8. egfr is a potential therapeutic target for highly glycosylated and aggressive pancreatic neuroendocrine neoplasms.
Xiao Z; Xu H; Strosberg JR; Lu R; Zhu X; Deng S; Ding L; Ni Q; Warshaw AL; Yu X; Luo G
Int J Cancer; 2023 Jul; 153(1):164-172. PubMed ID: 36891979
[TBL] [Abstract] [Full Text] [Related]
9. The Prognostic Value and the Oncogenic and Immunological Roles of Vacuolar Protein Sorting Associated Protein 26 A in pancreatic Adenocarcinoma.
Hou J; Wu H; Xu B; Shang J; Xu X; Li G; Zhang H; Zhang W; Deng Y; Hong X; Hu T; Zhang M; Zhan Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834898
[TBL] [Abstract] [Full Text] [Related]
10. Prediction of Biomarker Expression on Primary pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach.
Houvast RD; van Duijvenvoorde M; Chua J; Vankemmelbeke M; Durrant LG; Inderson A; van Hooft JE; Mieog JSD; Bonsing BA; Sier CFM; Crobach ASLP; Vahrmeijer AL; Kuppen PJK
Mol Diagn Ther; 2023 Mar; 27(2):261-273. PubMed ID: 36656512
[TBL] [Abstract] [Full Text] [Related]
11. Intraductal oncocytic papillary neoplasm arising in Peutz-Jeghers Syndrome bile duct: a unique case report.
Liu Q; Wang Z; Yu C; Zhu J; Liu C; Li X; Ren L; Li T
Diagn Pathol; 2022 Dec; 17(1):96. PubMed ID: 36578081
[TBL] [Abstract] [Full Text] [Related]
12. Early Application of Next-Generation Sequencing Identifies pancreatic Mass as Metastasis From an egfr-Mutated Lung Adenocarcinoma.
Chen L; Davelaar J; Gaddam S; Kosari K; Nissen N; Chaux G; Lee C; Vail E; Hendifar A; Gong J; Reckamp K; Osipov A
J Natl Compr Canc Netw; 2022 Nov; 21(1):6-11. PubMed ID: 36395704
[TBL] [Abstract] [Full Text] [Related]
13. Exosomal DNAJB11 promotes the development of pancreatic cancer by modulating the egfr/MAPK pathway.
Liu P; Zu F; Chen H; Yin X; Tan X
Cell Mol Biol Lett; 2022 Oct; 27(1):87. PubMed ID: 36209075
[TBL] [Abstract] [Full Text] [Related]
14. Immunohistochemical analysis of a panel of cancer stem cell markers and potential therapeutic markers in pancreatic ductal adenocarcinoma.
Ali SMA; Adnan Y; Ali SM; Ahmad Z; Chawla T; Farooqui HA
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2279-2292. PubMed ID: 36066622
[TBL] [Abstract] [Full Text] [Related]
15. An egfr-mutant lung adenocarcinoma that transformed into small-cell lung cancer. A case report.
Chowaniecova G; Berzinec P; Kosturiakova G; Plank L; Farkasova A; Sekeresova M; Juskanic D; Ondrus D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Dec; 166(4):451-454. PubMed ID: 36036563
[TBL] [Abstract] [Full Text] [Related]
16. Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities?
White VA; Hyrcza MD; Lennerz JK; Thierauf J; Lokuhetty D; Cree IA; Indave BI
Mod Pathol; 2022 Oct; 35(10):1484-1493. PubMed ID: 35871081
[TBL] [Abstract] [Full Text] [Related]
17. Saikosaponin-A Exhibits Antipancreatic cancer Activity by Targeting the egfr/PI3K/Akt Pathway.
Shi C; Sun L; Fang R; Zheng S; Yu M; Li Q
Curr Pharm Biotechnol; 2023; 24(4):579-588. PubMed ID: 35692139
[TBL] [Abstract] [Full Text] [Related]
18. Implication of erbb2 as a Predictive Tool for Survival in Patients with pancreatic cancer in Histological Studies.
Ortega MA; Pekarek L; Fraile-Martinez O; Garcia-Montero C; Saez MA; Asúnsolo A; Alvarez-Mon MA; Monserrat J; Ruiz-Llorente L; García-Honduvilla N; Albillos A; Buján J; Alvarez-Mon M; Guijarro LG
Curr Oncol; 2022 Mar; 29(4):2442-2453. PubMed ID: 35448172
[TBL] [Abstract] [Full Text] [Related]
19. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (egfrIs) and their Role in the Treatment of cancer: A Review.
Unnisa A; Chettupalli AK; Hussain T; Kamal MA
Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
[TBL] [Abstract] [Full Text] [Related]
20. Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer.
Sivapalan L; Thorn GJ; Gadaleta E; Kocher HM; Ross-Adams H; Chelala C
BMC Cancer; 2022 Apr; 22(1):369. PubMed ID: 35392854
[TBL] [Abstract] [Full Text] [Related]
[Next]